KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline

Hypertension is a modifiable risk factor for cardiovascular morbidity and mortality and reduction of elevated blood pressure (BP) remains an important intervention for slowing kidney disease progression. Over the past decade, the most appropriate BP target for initiation and titration of BP-lowering...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Am J Kidney Dis
Autores principales: Kramer, Holly J., Townsend, Raymond R., Griffin, Karen, Flynn, Joseph T., Weiner, Daniel E., Rocco, Michael V., Choi, Michael J., Weir, Matthew R., Chang, Tara I., Agarwal, Rajiv, Beddhu, Srinivasan
Formato: Artigo
Lenguaje:Inglês
Publicado: 2019
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6740329/
https://ncbi.nlm.nih.gov/pubmed/30905361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.ajkd.2019.01.007
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares